Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence

被引：0
|
作者：
Caponnetto, S. [1 ]
Gelibter, A. [2 ]
Mosillo, C. [2 ]
Magri, V. [2 ]
Scagnoli, S. [2 ]
Pomati, G. [2 ]
Piesco, G. [2 ]
Verkhovskaya, S. [2 ]
Pisegna, S. [2 ]
Sirgiovanni, G. [2 ]
Napoli, V. [2 ]
Buscicchio, D. [2 ]
Iannantuono, G. M. [2 ]
Marinelli, D. [2 ]
Mammone, G. [2 ]
Pannunzio, S. [2 ]
Nicolo, E. [2 ]
Stefani, A. [2 ]
Astorino, V. [2 ]
Mancini, M. [2 ]
Cortesi, E. [2 ]
机构：
[1] Univ Roma La Sapienza, Oncol Med B, Policlin Umberto I, Rome, Italy
[2] Policlin Umberto 1, Oncol Med B, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
D27
引用
收藏
页数：1
相关论文
共 50 条
  • [21] First-Line Gemcitabine, Nab-Paclitaxel, and Oxaliplatin Chemotherapy With Itraconazole in Patients With Metastatic Pancreatic Cancer: A Single Institution Experience
    Sawasaki, Miyuki
    Tsubamoto, Hiroshi
    Sugihara, Ayako
    Ikuta, Shinichi
    Sakai, Yoshiyuki
    Osaki, Yukio
    Sonoda, Takashi
    ANTICANCER RESEARCH, 2022, 42 (12) : 6063 - 6069
  • [22] Eligibility of Metastatic Pancreatic Cancer Patients for First-Line Palliative Intent nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX
    Peixoto, Renata D.
    Ho, Maria
    Renouf, Daniel J.
    Lim, Howard J.
    Gill, Sharlene
    Ruan, Jenny Y.
    Cheung, Winson Y.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (05): : 507 - 511
  • [23] First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population
    Hatashima, Alycia
    Arango, Matthew J.
    Reardon, Joshua
    Freeman, Tracelyn
    Williams, Terence
    McLaughlin, Eric M.
    Abushahin, Laith
    FUTURE ONCOLOGY, 2022, 18 (20) : 2521 - 2532
  • [24] Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
    Sezgin, Yasin
    Karhan, Ogur
    Aldemir, Mehmet Naci
    Urun, Muslih
    Ercek, Berrak Mermit
    Urakci, Zuhat
    Arvas, Hayati
    Tunc, Sezai
    Erdem, Mehmet
    Yerlikaya, Halis
    Ileri, Serdar
    Aydin, Ibrahim
    Bicer, Abdurrahman
    Komuroglu, Ahmet Ufuk
    Majidova, Nargiz
    Gokcek, Savas
    Demir, Hacer
    Yildiz, Sedat
    Akbas, Sinem
    Ozen, Esra
    Kahya, Burcu Ulas
    Sali, Muersel
    Anik, Hicran
    Aykut, Talat
    Araz, Murat
    Alkan, Ali
    Ozcelik, Melike
    Sakin, Abudllah
    Aykan, Musa Baris
    Mehtiyev, Mirmehdi
    Demir, Bilgin
    Baser, Mehmet Nuri
    Sonmez, Muge
    Gulturk, Ilkay
    Avci, Niluever
    Urvay, Semiha
    Arici, Mustafa Ozgur
    Kalender, Mehmet Emin
    Yildirim, Mustafa
    Solmaz, Ali Alper
    Gurbuz, Mustafa
    Ergun, Yakup
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [25] Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
    Sezgin, Y.
    Karhan, O.
    Urakci, Z.
    Mecidova, N.
    Araz, M.
    Sakin, A.
    Ercek, B. M.
    Urun, M.
    Urvay, S.
    Aykan, M. B.
    Kocak, S.
    Arici, M. O.
    Avci, N.
    Alkan, A.
    Ozcelik, M.
    Aldemir, M. N.
    Ergun, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S930 - S930
  • [26] Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy following FOLFIRINOX in Patients with Unresectable Pancreatic Cancer: A Single-Institution, Retrospective Analysis
    Hayuka, Kotone
    Okuyama, Hiroyuki
    Murakami, Akitsu
    Okita, Yoshihiro
    Nishiuchi, Takamasa
    Okano, Keiichi
    Suzuki, Yasuyuki
    Tsuji, Akihito
    CHEMOTHERAPY, 2021, 66 (03) : 58 - 64
  • [27] Exceptional Response to Second-Line Gemcitabine/Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Adenocarcinoma
    Bukhari, Nedal
    Abdalla, Khalda
    Ibnshamsa, Fahad
    Alselwi, Waleed
    Al-Shakir, Shakir
    Alqahtani, Mohammed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [28] Chemotherapy in Pancreatic Cancer: Comparative Study of Gemcitabine, S-1, and FOLFIRINOX, Nab-Paclitaxel plus Gem
    Miyata, H.
    Yamago, H.
    Ueki, H.
    Nagamatsu, K.
    Iwasaki, R.
    PANCREAS, 2019, 48 (10) : 1492 - 1492
  • [29] Gemcitabine/nab-paclitaxel as second-line therapy following FOLFIRINOX in metastatic/advanced pancreatic cancer-retrospective analysis of response
    Nguyen, Khanh T.
    Kalyan, Aparna
    Beasley, H. Scott
    Singhi, Aatur D.
    Sun, Weijing
    Zeh, Herbert J.
    Normolle, Daniel
    Bahary, Nathan
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (03) : 556 - 565
  • [30] Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis
    Pusceddu, Sara
    Ghidini, Michele
    Torchio, Martina
    Corti, Francesca
    Tomasello, Gianluca
    Niger, Monica
    Prinzi, Natalie
    Nichetti, Federico
    Coinu, Andrea
    Di Bartolomeo, Maria
    Cabiddu, Mary
    Passalacqua, Rodolfo
    de Braud, Filippo
    Petrelli, Fausto
    CANCERS, 2019, 11 (04)
12345